Tokyo – September 28, 2026 -- SOLA Biosciences Japan GK has secured a grant of approximately 6 billion yen over five years from Japan's Agency for Medical Research and Development (AMED) to advance SOL-257, a gene therapy candidate targeting the TDP-43 protein implicated in amyotrophic lateral sclerosis (ALS). The award, granted under AMED's Strengthening Program for Pharmaceutical Startup Ecosystem, was announced June 5, 2026, and positions SOLA Japan as the company's central development hub for the program.

Stockholm – September 28, 2026 -- Telefonaktiebolaget LM Ericsson repurchased Class B shares on Nasdaq Stockholm during the week of September 21-25, 2026, lifting its total treasury stock holding to 108,518,663 Class B shares.

Shanghai – September 26, 2026 -- IASO Biotechnology reported a 90% objective response rate and 90% minimal residual disease (MRD) negativity rate for its BCMA-targeted in vivo CAR-T therapy IASO206, generated via a single intravenous infusion without lymphodepleting chemotherapy, in first-in-human Phase 1 data presented as a late-breaking oral session (LBA-11) at the 2026 International Myeloma Society Annual Meeting.

Whitefish, Mont. – September 25, 2026 -- STEMREGEN, a maker of science-backed stem cell supplements, has landed at No. 332 on the 2026 Inc. 5000 list after posting 1,017% revenue growth over three years, far outpacing the list's 130% median.

Company secures third straight Inc. 5000 ranking as growth trajectory accelerates

STEMREGEN previously ranked No. 265 in 2025 and No. 1,765 in 2024, marking three consecutive years on the annual list of America's fastest-growing private companies. The 2026 ranking measures revenue growth from 2022 through 2025.

Irvine, Calif. – September 25, 2026 -- Sunwest Bank has acquired Nano Banc of Irvine, California, in an FDIC-assisted transaction that transfers approximately $605 million in deposits and $227 million in loans to the Sandy, Utah-based lender.

Boston – – September 25, 2026 -- MagLev Aero has secured concurrent contracts from the Defense Advanced Research Projects Agency under its Minimum Viable Product (MVP) and Embedded Entrepreneur Initiative (EEI) programs, providing non-dilutive funding to push its propulsion platform to Technology Readiness Level 6 (TRL-6).

Sand Springs, Okla. – September 25, 2026 -- Webco Industries, Inc. (OTC: WEBC) reported fiscal 2026 net income of $18.3 million, or $26.50 per diluted share, nearly double the $9.3 million, or $12.30 per diluted share, earned in fiscal 2025.

Southlake, Texas – September 25, 2026 -- Sabre Corporation (Nasdaq: SABR) disclosed that its indirect subsidiary, Sabre Financial Borrower, LLC, has secured tenders exceeding 90% of the aggregate principal amount outstanding on its targeted securities as of the September 25, 2026 early tender deadline, clearing the threshold required to force redemption of the remaining debt.

Cambridge, Mass. – September 25, 2026 -- NeuroSense Therapeutics (NASDAQ: NRSN) cut operating expenses to $3.4 million in the first half of 2026, down from $4.7 million a year earlier, as the biotech pushes its ALS candidate PrimeC toward a Canadian regulatory filing targeted for December 2026.

Houston – September 25, 2026 -- KLX Energy Services Holdings (Nasdaq: KLXE) has tightened its third-quarter 2026 revenue guidance to a range of $180 million to $185 million, implying a 9% sequential improvement over the second quarter.